S. Bilgin Et Al. , "A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus," Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.7, pp.928-930, 2022
Bilgin, S. Et Al. 2022. A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus. Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.7 , 928-930.
Bilgin, S., Duman, T. T., Kurtkulagi, Ö., Yilmaz, F., & Aktas, G., (2022). A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus. Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.7, 928-930.
Bilgin, Satilmis Et Al. "A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus," Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.7, 928-930, 2022
Bilgin, Satilmis Et Al. "A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus." Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.7, pp.928-930, 2022
Bilgin, S. Et Al. (2022) . "A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus." Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.7, pp.928-930.
@article{article, author={Satilmis Bilgin Et Al. }, title={A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus}, journal={Journal of the College of Physicians and Surgeons Pakistan}, year=2022, pages={928-930} }